Literature DB >> 15358592

Tachykinin-mediated modulation of the immune response.

Kenneth L Bost1.   

Abstract

Tachykinins represent a family of peptides which have significant effects on such diverse physiological responses as gut peristalsis, vascular permeability, and the transmission of pain. Traditionally, neurons have been identified as the major source of tachykinin peptides in peripheral tissues and in the central nervous system, resulting in their classification as neuropeptides or, more specifically, as neurokinins. The fact that a variety of cell types can express one or more members of the family of neurokinin receptors accounts for the remarkable ability of these tachykinin peptides to affect multiple organ systems and numerous biological responses. Perhaps one of the most surprising findings during the last 15 years has been the understanding that expression of neurokinin receptors on leukocyte populations can be constitutive or inducible. This fact establishes a receptor-mediated mechanism by which tachykinin peptides can affect both innate and specific immune responses. Due to the numerous cytokines, chemokines, and other soluble mediators that can modulate leukocyte responses, the importance of tachykinin-mediated modulation of the immune response has met with some skepticism. The following reviews make a strong case for neurokinin receptor expression by leukocytes as a significant participant in host response. From hematopoiesis to antigen-specific T lymphocyte responses, tachykinins are present and can dramatically modulate maturation and responsiveness of these immune cells. Studies which document this surprising role for neurokinin receptor expression by leukocytes are detailed in the following reviews.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15358592     DOI: 10.2741/1484

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  23 in total

1.  Measurement of plasma-derived substance P: biological, methodological, and statistical considerations.

Authors:  Donald E Campbell; Nancy Raftery; Richard Tustin; Nancy B Tustin; Michelle L Desilvio; Avital Cnaan; Pyone Pyone Aye; Andrew A Lackner; Steven D Douglas
Journal:  Clin Vaccine Immunol       Date:  2006-09-13

Review 2.  Neurokinin-1 receptor: functional significance in the immune system in reference to selected infections and inflammation.

Authors:  Steven D Douglas; Susan E Leeman
Journal:  Ann N Y Acad Sci       Date:  2010-11-22       Impact factor: 5.691

3.  Modulation of lymphatic muscle contractility by the neuropeptide substance P.

Authors:  Michael J Davis; Megan M Lane; Ann M Davis; David Durtschi; David C Zawieja; Mariappan Muthuchamy; Anatoliy A Gashev
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-06       Impact factor: 4.733

4.  Immunostimulatory effects of mesenchymal stem cell-derived neurons: implications for stem cell therapy in allogeneic transplantations.

Authors:  Marianne D Castillo; Katarzyna A Trzaska; Steven J Greco; Nicholas M Ponzio; Pranela Rameshwar
Journal:  Clin Transl Sci       Date:  2008-05       Impact factor: 4.689

5.  Substance P-neurokinin-1 receptor interaction upregulates monocyte tissue factor.

Authors:  Mohammad M Khan; Steven D Douglas; Tami D Benton
Journal:  J Neuroimmunol       Date:  2011-11-23       Impact factor: 3.478

6.  Full-length and truncated neurokinin-1 receptor expression and function during monocyte/macrophage differentiation.

Authors:  J-P Lai; W Z Ho; L E Kilpatrick; X Wang; F Tuluc; H M Korchak; S D Douglas
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-04       Impact factor: 11.205

7.  Substance P inhibits natural killer cell cytotoxicity through the neurokinin-1 receptor.

Authors:  Linda Monaco-Shawver; Lynnae Schwartz; Florin Tuluc; Chang-Jiang Guo; Jian Ping Lai; Satya M Gunnam; Laurie E Kilpatrick; Pinaki P Banerjee; Steven D Douglas; Jordan S Orange
Journal:  J Leukoc Biol       Date:  2010-10-12       Impact factor: 4.962

8.  Detection of full-length and truncated neurokinin-1 receptor mRNA expression in human brain regions.

Authors:  Jian-Ping Lai; Avital Cnaan; Huaqing Zhao; Steven D Douglas
Journal:  J Neurosci Methods       Date:  2007-10-17       Impact factor: 2.390

9.  Substance P (SP) enhances CCL5-induced chemotaxis and intracellular signaling in human monocytes, which express the truncated neurokinin-1 receptor (NK1R).

Authors:  Irene Chernova; Jian-Ping Lai; Haiying Li; Lynnae Schwartz; Florin Tuluc; Helen M Korchak; Steven D Douglas; Laurie E Kilpatrick
Journal:  J Leukoc Biol       Date:  2008-10-03       Impact factor: 4.962

10.  Effects of COX inhibition and LPS on formalin induced pain in the infant rat.

Authors:  Deirtra Hunter; Christina Chai; Gordon A Barr
Journal:  Dev Neurobiol       Date:  2014-09-13       Impact factor: 3.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.